nabumetone (BioDeep_00000016589)
natural product
代谢物信息卡片
nabumetone
化学式: C15H16O2 (228.1150236)
中文名称: 萘丁美酮
谱图信息:
最多检出来源 () 0%
分子结构信息
SMILES: C1(=CC=C2C(=C1)C=CC(=C2)CCC(C)=O)OC
InChI: InChI=1S/C15H16O2/c1-11(16)3-4-12-5-6-14-10-15(17-2)8-7-13(14)9-12/h5-10H,3-4H2,1-2H3
描述信息
M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids
D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors
D004791 - Enzyme Inhibitors > D016861 - Cyclooxygenase Inhibitors > D052246 - Cyclooxygenase 2 Inhibitors
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic
D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents
D002491 - Central Nervous System Agents > D000700 - Analgesics
D000893 - Anti-Inflammatory Agents
同义名列表
1 个代谢物同义名
数据库引用编号
10 个数据库交叉引用编号
- ChEBI: CHEBI:7443
- KEGG: C07237
- KEGGdrug: D00425
- PubChem: 4409
- Metlin: METLIN1367
- DrugBank: DB00461
- ChEMBL: CHEMBL1070
- MeSH: Nabumetone
- CAS: 42924-53-8
- MoNA: CCMSLIB00000078641
分类词条
相关代谢途径
Reactome(0)
BioCyc(0)
PlantCyc(0)
代谢反应
0 个相关的代谢反应过程信息。
Reactome(0)
BioCyc(0)
WikiPathways(0)
Plant Reactome(0)
INOH(0)
PlantCyc(0)
COVID-19 Disease Map(0)
PathBank(0)
PharmGKB(0)
0 个相关的物种来源信息
在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：
- PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
- NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
- Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
- Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。
点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。
文献列表
- Dominika Kapuścińska, Magdalena Narajczyk, Ivan Liakh, Bartosz Wielgomas, Anna Aksmann. Nabumetone and flufenamic acid pose a serious risk to aquatic plants: A study with Chlamydomonas reinhardtii as a model organism.
Chemosphere.
2024 Feb; 349(?):140853. doi:
10.1016/j.chemosphere.2023.140853. [PMID: 38052310] - Anik Banik, Sheikh Rashel Ahmed, Emran Hossain Sajib, Anamika Deb, Shiuly Sinha, Kazi Faizul Azim. Identification of potential inhibitory analogs of metastasis tumor antigens (MTAs) using bioactive compounds: revealing therapeutic option to prevent malignancy.
Molecular diversity.
2022 Oct; 26(5):2473-2502. doi:
10.1007/s11030-021-10345-w. [PMID: 34743299] - Saba Qureshi, Sonam Chandra, Deepti Chopra, Divya Dubey, Veena Jain, Somendu Kumar Roy, Ratan Singh Ray. Nabumetone induced photogenotoxicity mechanism mediated by ROS generation under environmental UV radiation in human keratinocytes (HaCaT) cell line.
Toxicology and applied pharmacology.
2021 06; 420(?):115516. doi:
10.1016/j.taap.2021.115516. [PMID: 33798594] - Mark J Henderson, Kathleen A Trychta, Shyh-Ming Yang, Susanne Bäck, Adam Yasgar, Emily S Wires, Carina Danchik, Xiaokang Yan, Hideaki Yano, Lei Shi, Kuo-Jen Wu, Amy Q Wang, Dingyin Tao, Gergely Zahoránszky-Kőhalmi, Xin Hu, Xin Xu, David Maloney, Alexey V Zakharov, Ganesha Rai, Fumihiko Urano, Mikko Airavaara, Oksana Gavrilova, Ajit Jadhav, Yun Wang, Anton Simeonov, Brandon K Harvey. A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
Cell reports.
2021 04; 35(4):109040. doi:
10.1016/j.celrep.2021.109040. [PMID: 33910017] - Roya Afsharipour, Shayessteh Dadfarnia, Ali Mohammad Haji Shabani, Elahe Kazemi. Design of a pseudo stir bar sorptive extraction using graphenized pencil lead as the base of the molecularly imprinted polymer for extraction of nabumetone.
Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.
2020 Sep; 238(?):118427. doi:
10.1016/j.saa.2020.118427. [PMID: 32388234] - Raj Kumar, Ashutosh Singh, Kajal Sharma, Divya Dhasmana, Neha Garg, Prem Felix Siril. Preparation, characterization and in vitro cytotoxicity of Fenofibrate and Nabumetone loaded solid lipid nanoparticles.
Materials science & engineering. C, Materials for biological applications.
2020 Jan; 106(?):110184. doi:
10.1016/j.msec.2019.110184. [PMID: 31753394] - Tobie D Lee, Olivia W Lee, Kyle R Brimacombe, Lu Chen, Rajarshi Guha, Sabrina Lusvarghi, Bethilehem G Tebase, Carleen Klumpp-Thomas, Robert W Robey, Suresh V Ambudkar, Min Shen, Michael M Gottesman, Matthew D Hall. A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Molecular pharmacology.
2019 11; 96(5):629-640. doi:
10.1124/mol.119.115964. [PMID: 31515284] - Lenka Jourova, Pavel Anzenbacher, Zuzana Matuskova, Rostislav Vecera, Jan Strojil, Milan Kolar, Milan Nobilis, Petra Hermanova, Tomas Hudcovic, Hana Kozakova, Miloslav Kverka, Eva Anzenbacherova. Gut microbiota metabolizes nabumetone in vitro: Consequences for its bioavailability in vivo in the rodents with altered gut microbiome.
Xenobiotica; the fate of foreign compounds in biological systems.
2019 Nov; 49(11):1296-1302. doi:
10.1080/00498254.2018.1558310. [PMID: 30794062] - Filippo Fiorentini, Elvira Romero, Marco W Fraaije, Kurt Faber, Mélanie Hall, Andrea Mattevi. Baeyer-Villiger Monooxygenase FMO5 as Entry Point in Drug Metabolism.
ACS chemical biology.
2017 09; 12(9):2379-2387. doi:
10.1021/acschembio.7b00470. [PMID: 28783300] - Aishwarya Balap, Sathiyanarayanan Lohidasan, Arulmozhi Sinnathambi, Kakasaheb Mahadik. Pharmacokinetic and Pharmacodynamic Interaction of Andrographolide and Standardized Extract of Andrographis paniculata (Nees) with Nabumetone in Wistar Rats.
Phytotherapy research : PTR.
2017 Jan; 31(1):75-80. doi:
10.1002/ptr.5731. [PMID: 27714886] - Mohammad Asadi, Ali Mohammad Haji Shabani, Shayessteh Dadfarnia, Bijan Abbasi. Vortex-assisted surfactant-enhanced emulsification microextraction based on solidification of floating organic drop combined with high performance liquid chromatography for determination of naproxen and nabumetone.
Journal of chromatography. A.
2015 Dec; 1425(?):17-24. doi:
10.1016/j.chroma.2015.11.005. [PMID: 26627589] - Sunna Þorsteinsdóttir, Marie Juul Velander, Anette Bygum. [Medicine-caused itch, wounds and bullous skin in three patients with pseudoporphyria].
Ugeskrift for laeger.
2015 Apr; 177(17):. doi:
NULL. [PMID: 25922166] - Iva Boušová, Lenka Skálová, Pavel Souček, Petra Matoušková. The modulation of carbonyl reductase 1 by polyphenols.
Drug metabolism reviews.
2015; 47(4):520-33. doi:
10.3109/03602532.2015.1089885. [PMID: 26415702] - M A Onuigbo, N Agbasi. 'Quadruple whammy'- a preventable newly described syndrome of post-operative AKI in CKD II and CKD III patients on combination 'Triple whammy' medications: a Mayo Clinic Health System, Eau Claire, Wisconsin experience.
Nigerian journal of clinical practice.
2014 Sep; 17(5):649-54. doi:
10.4103/1119-3077.141440. [PMID: 25244280] - Hung-Yen Chin, Eileen Changchien, Mei-Fung Lin, Chi-Hsin Chiang, Chin-Jung Wang. Concentration of non-steroidal anti-inflammatory drugs in the pelvic floor muscles: an experimental comparative rat model.
Yonsei medical journal.
2014 Jul; 55(4):1095-100. doi:
10.3349/ymj.2014.55.4.1095. [PMID: 24954342] - Lenka Česlová, Michal Holčapek, Milan Nobilis. Identification of combined conjugation of nabumetone phase I metabolites with glucuronic acid and glycine in minipig biotransformation using coupling high-performance liquid chromatography with electrospray ionization mass spectrometry.
Journal of pharmaceutical and biomedical analysis.
2014 Jan; 88(?):221-4. doi:
10.1016/j.jpba.2013.08.053. [PMID: 24083957] - M Consuelo Jiménez, Miguel A Miranda. Triplet excited States as a source of relevant (bio)chemical information.
Current topics in medicinal chemistry.
2014; 14(23):2734-42. doi:
10.2174/1568026614666141216100907. [PMID: 25515745] - Lihong Chen, Guangrui Yang, Tilo Grosser. Prostanoids and inflammatory pain.
Prostaglandins & other lipid mediators.
2013 Jul; 104-105(?):58-66. doi:
10.1016/j.prostaglandins.2012.08.006. [PMID: 22981510] - Nao Setoguchi, Norito Takamura, Ken-ichi Fujita, Kenji Ogata, Jin Tokunaga, Toyotaka Nishio, Etsuo Chosa, Kazuhiko Arimori, Keiichi Kawai, Ryuichi Yamamoto. A diclofenac suppository-nabumetone combination therapy for arthritic pain relief and a monitoring method for the diclofenac binding capacity of HSA site II in rheumatoid arthritis.
Biopharmaceutics & drug disposition.
2013 Mar; 34(2):125-36. doi:
10.1002/bdd.1829. [PMID: 23225308] - José Antonio Murillo Pulgarín, Aurelia Alañón Molina, Fernando Martínez Ferreras. Simultaneous determination of nabumetone and its principal metabolite in medicines and human urine by time-resolved fluorescence.
The Analyst.
2012 Nov; 137(21):5144-52. doi:
10.1039/c2an35412h. [PMID: 22977877] - Robert L Jackson, Barbara Hunt, Patricia A MacDonald. The efficacy and safety of febuxostat for urate lowering in gout patients ≥65 years of age.
BMC geriatrics.
2012 Mar; 12(?):11. doi:
10.1186/1471-2318-12-11. [PMID: 22436129] - Jean-Pascal Fournier, Maryse Lapeyre-Mestre, Agnès Sommet, Julie Dupouy, Jean-Christophe Poutrain, Jean-Louis Montastruc. Laboratory monitoring of patients treated with antihypertensive drugs and newly exposed to non steroidal anti-inflammatory drugs: a cohort study.
PloS one.
2012; 7(3):e34187. doi:
10.1371/journal.pone.0034187. [PMID: 22479557] - Takako Hirata, Shuh Narumiya. Prostanoids as regulators of innate and adaptive immunity.
Advances in immunology.
2012; 116(?):143-74. doi:
10.1016/b978-0-12-394300-2.00005-3. [PMID: 23063076] - Kang Nyeong Lee, Oh Young Lee, Myung-Gyu Choi, Seok Reyol Choi, Dong Ho Lee, Yong Chan Lee, Tae Nyeun Kim, Suck Chei Choi, Jong Sun Rew, Sang-Yong Seol. Prevention of NSAID-associated gastroduodenal injury in healthy volunteers-a randomized, double-blind, multicenter study comparing DA-9601 with misoprostol.
Journal of Korean medical science.
2011 Aug; 26(8):1074-80. doi:
10.3346/jkms.2011.26.8.1074. [PMID: 21860559] - Sandeep Rahar, Gaurav Swami, Navneet Nagpal, Manisha A Nagpal, Gagan Shah Singh. Preparation, characterization, and biological properties of β-glucans.
Journal of advanced pharmaceutical technology & research.
2011 Apr; 2(2):94-103. doi:
10.4103/2231-4040.82953. [PMID: 22171300] - Lenka Nespesná, Martin Stícha, Olga Matousková, Frantisek Perlík, Ondrej Slanar. [Determination of nabumetone and 6-methoxy-2-naphthylacetic acid in plasma using HPLC with UV and MS detection].
Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti.
2011 Feb; 60(1):17-24. doi:
NULL. [PMID: 21650014] - Rahila Ahmad Pathan, Bhulan Kumar Singh, K K Pillai, Kiran Dubey. Naproxen aggravates doxorubicin-induced cardiomyopathy in rats.
Indian journal of pharmacology.
2010 Feb; 42(1):44-9. doi:
10.4103/0253-7613.62411. [PMID: 20606837] - Sunday Olakunle Idowu, Morenikeji Ambali Adeyemo, Udochi Ihechiluru Ogbonna. Engineering and validation of a novel lipid thin film for biomembrane modeling in lipophilicity determination of drugs and xenobiotics.
Journal of biological engineering.
2009 Sep; 3(?):14. doi:
10.1186/1754-1611-3-14. [PMID: 19735551] - Keiichi Kawai, Ryuichi Nishii, Naoto Shikano, Nobuo Makino, Noriyuki Kuga, Mitsuyoshi Yoshimoto, Seishi Jinnouchi, Shigeki Nagamachi, Shozo Tamura, Norito Takamura. Serum protein binding displacement: theoretical analysis using a hypothetical radiopharmaceutical and experimental analysis with 123I-N-isopropyl-p-iodoamphetamine.
Nuclear medicine and biology.
2009 Jan; 36(1):99-106. doi:
10.1016/j.nucmedbio.2008.10.005. [PMID: 19181274] - Bhavin N Patel, Naveen Sharma, Mallika Sanyal, Arpana Prasad, Pranav S Shrivastav. High-throughput LC-MS/MS assay for 6-methoxy-2-naphthylacetic acid, an active metabolite of nabumetone in human plasma and its application to bioequivalence study.
Biomedical chromatography : BMC.
2008 Nov; 22(11):1213-24. doi:
10.1002/bmc.1047. [PMID: 18651608] - Klefah A K Musa, Leif A Eriksson. Theoretical study of the phototoxicity of naproxen and the active form of nabumetone.
The journal of physical chemistry. A.
2008 Oct; 112(43):10921-30. doi:
10.1021/jp805614y. [PMID: 18834087] - Mojca Brunskole, Bogdan Stefane, Karmen Zorko, Marko Anderluh, Jure Stojan, Tea Lanisnik Rizner, Stanislav Gobec. Towards the first inhibitors of trihydroxynaphthalene reductase from Curvularia lunata: synthesis of artificial substrate, homology modelling and initial screening.
Bioorganic & medicinal chemistry.
2008 Jun; 16(11):5881-9. doi:
10.1016/j.bmc.2008.04.066. [PMID: 18482840] - Idris bin Long, Harbindar Jeet Singh, Gurubelli Janardhana Rao. Comparative effects of indomethacin and nabumetone on urine and electrolyte output in conscious rats.
Journal of pharmacological sciences.
2005 Nov; 99(3):272-6. doi:
10.1254/jphs.fpj05008x. [PMID: 16293937] - N Canudas, D Zamora, J E Villamizar, J Fuentes, C Castelli, A Taddei. Photosensitizing properties of 6-methoxy-2-naphthylacetic acid, the major metabolite of the phototoxic non-steroidal anti-inflammatory and analgesic drug nabumetone.
Die Pharmazie.
2005 Aug; 60(8):604-8. doi:
". [PMID: 16124404] - R Nageswara Rao, S Meena, D Nagaraju, A Raghu Ram Rao. Development and validation of a reversed-phase liquid chromatographic method for separation and simultaneous determination of COX-2 inhibitors in pharmaceuticals and its application to biological fluids.
Biomedical chromatography : BMC.
2005 Jun; 19(5):362-8. doi:
10.1002/bmc.458. [PMID: 15627281] - J A Murillo Pulgarín, A Alañón Molina, M T Alañón Pardo. Simplex optimization of the variables affecting the micelle-stabilized room temperature phosphorescence of 6-methoxy-2-naphthylacetic acid and its kinetic determination in human urine.
Analytical biochemistry.
2005 Apr; 339(1):157-64. doi:
10.1016/j.ab.2005.01.012. [PMID: 15766723] - J F Sheen, G R Her. Application of pentafluorophenyl hydrazine derivatives to the analysis of nabumetone and testosterone in human plasma by liquid chromatography-atmospheric pressure chemical ionization-tandem mass spectrometry.
Analytical and bioanalytical chemistry.
2004 Dec; 380(7-8):891-7. doi:
10.1007/s00216-004-2877-6. [PMID: 15700167] - M Nobilis, M Holcapek, L Kolárová, J Kopecký, M Kunes, Z Svoboda, J Kvetina. Identification and determination of phase II nabumetone metabolites by high-performance liquid chromatography with photodiode array and mass spectrometric detection.
Journal of chromatography. A.
2004 Mar; 1031(1-2):229-36. doi:
10.1016/j.chroma.2004.01.031. [PMID: 15058587] - Thomas Hedner, Ola Samulesson, Peter Währborg, Hans Wadenvik, Kjell-Arne Ung, Anders Ekbom. Nabumetone: therapeutic use and safety profile in the management of osteoarthritis and rheumatoid arthritis.
Drugs.
2004; 64(20):2315-43; discussion 2344. doi:
10.2165/00003495-200464200-00004. [PMID: 15456329] - M Nobilis, J Kopecký, J Kvetina, Z Svoboda, M Pour, J Kunes, M Holcapek, L Kolárová. Comparative biotransformation and disposition studies of nabumetone in humans and minipigs using high-performance liquid chromatography with ultraviolet, fluorescence and mass spectrometric detection.
Journal of pharmaceutical and biomedical analysis.
2003 Aug; 32(4-5):641-56. doi:
10.1016/s0731-7085(03)00171-7. [PMID: 12899954] - H T Sørensen, S Friis, B Nørgård, L Mellemkjaer, W J Blot, J K McLaughlin, A Ekbom, J A Baron. Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study.
British journal of cancer.
2003 Jun; 88(11):1687-92. doi:
10.1038/sj.bjc.6600945. [PMID: 12771981] - Kamila Kobylińska, Małgorzata Barlińska, Maria Kobylińska. Analysis of nabumetone in human plasma by HPLC. Application to single dose pharmacokinetic studies.
Journal of pharmaceutical and biomedical analysis.
2003 Jun; 32(2):323-8. doi:
10.1016/s0731-7085(03)00078-5. [PMID: 12763542] - Jeffrey R LaDuca, Peter H Bouman, Anthony A Gaspari. Nonsteroidal antiinflammatory drug-induced pseudoporphyria: a case series.
Journal of cutaneous medicine and surgery.
2002 Jul; 6(4):320-6. doi:
10.1007/s10227-001-0051-8. [PMID: 12118363] - D J W van Kraaij, A H I Hovestad-Witterland, M de Metz, E J Vollaard. A comparison of the effects of nabumetone vs meloxicam on serum thromboxane B2 and platelet function in healthy volunteers.
British journal of clinical pharmacology.
2002 Jun; 53(6):644-7. doi:
10.1046/j.1365-2125.2002.01605.x. [PMID: 12047490] - F Giuliano, J G Ferraz, R Pereira, G de Nucci, T D Warner. Cyclooxygenase selectivity of non-steroid anti-inflammatory drugs in humans: ex vivo evaluation.
European journal of pharmacology.
2001 Aug; 426(1-2):95-103. doi:
10.1016/s0014-2999(01)01207-9. [PMID: 11525777] - N Giordano, E Battisti, M Fortunato, C Santacroce, S Geraci, V Tanganelli, G Mattii, C Gennari, L Gennari, M Rigato. [Evaluation of early biomarkers of cartilage degeneration in the diagnosis and clinico-therapeutic monitoring of primary osteoarthrosis].
La Clinica terapeutica.
2001 May; 152(3):179-82. doi:
NULL. [PMID: 11692536] - J Reichman, S Cohen, M Goldfarb, A Shina, S Rosen, M Brezis, F Karmeli, S N Heyman. Renal effects of nabumetone, a COX-2 antagonist: impairment of function in isolated perfused rat kidneys contrasts with preserved renal function in vivo.
Experimental nephrology.
2001; 9(6):387-96. doi:
10.1159/000052637. [PMID: 11701998] - E Mikami, T Goto, T Ohno, H Matsumoto, M Nishida. Simultaneous analysis of naproxen, nabumetone and its major metabolite 6-methoxy-2-naphthylacetic acid in pharmaceuticals and human urine by high-performance liquid chromatography.
Journal of pharmaceutical and biomedical analysis.
2000 Oct; 23(5):917-25. doi:
10.1016/s0731-7085(00)00365-4. [PMID: 11022916] - A D de Jager, H K Hundt, A F Hundt, K J Swart, M Knight, J Roberts. Extractionless determination of 6-methoxy-2-naphthylacetic acid, a major metabolite of nabumetone, in human plasma by high-performance liquid chromatography.
Journal of chromatography. B, Biomedical sciences and applications.
2000 Apr; 740(2):247-51. doi:
10.1016/s0378-4347(00)00074-8. [PMID: 10821411] - N Canudas, J Moulinier, D Zamora, A Sánchez. Photobiological properties of nabumetone (4-[6-methoxy-2-naphthalenyl]-2-butanone), a novel non-steroidal anti-inflammatory and analgesic agent.
Die Pharmazie.
2000 Apr; 55(4):282-5. doi:
". [PMID: 10798241] - N M Davies, A J McLachlan. [Properties and features of nabumetone].
Drugs.
2000; 59 Spec No 1(?):25-33. doi:
10.2165/00003495-200059991-00004. [PMID: 10841070] - J C Silva, M F Rocha, A A Lima, G A Brito, D B de Menezes, V S Rao. Effects of pentoxifylline and nabumetone on the serum levels of IL-1beta and TNFalpha in rats with adjuvant arthritis.
Inflammation research : official journal of the European Histamine Research Society ... [et al.].
2000 Jan; 49(1):14-9. doi:
10.1007/pl00000198. [PMID: 10778916] - J W Freston. Rationalizing cyclooxygenase (COX) inhibition for maximal efficacy and minimal adverse events.
The American journal of medicine.
1999 Dec; 107(6A):78S-88S; discussion 89S. doi:
10.1016/s0002-9343(99)00371-x. [PMID: 10628597] - D C Brater. Effects of nonsteroidal anti-inflammatory drugs on renal function: focus on cyclooxygenase-2-selective inhibition.
The American journal of medicine.
1999 Dec; 107(6A):65S-70S; discussion 70S. doi:
10.1016/s0002-9343(99)00369-1. [PMID: 10628595] - Y Qin, Y Zou, M Liang, Y Huang, Q Yu. [Determination of 6-methoxy-2-naphthylacetic acid, a major metabolite of nabumetone, in human plasma by HPLC].
Hua xi yi ke da xue xue bao = Journal of West China University of Medical Sciences = Huaxi yike daxue xuebao.
1999 Dec; 30(4):452-4. doi:
NULL. [PMID: 11387968] - N V Olsen, N G Jensen, J M Hansen, N J Christensen, N Fogh-Andersen, I L Kanstrup. Non-steroidal anti-inflammatory drugs and renal response to exercise: a comparison of indomethacin and nabumetone.
Clinical science (London, England : 1979).
1999 Oct; 97(4):457-65. doi:
NULL. [PMID: 10491346] - V Thakur, M E Cook, J D Wallin. Antihypertensive effect of the combination of fosinopril and HCTZ is resistant to interference by nonsteroidal antiinflammatory drugs.
American journal of hypertension.
1999 Sep; 12(9 Pt 1):925-8. doi:
10.1016/s0895-7061(99)00075-8. [PMID: 10509552] - J L Cangiano, J Figueroa, R Palmer. Renal hemodynamic effects of nabumetone, sulindac, and placebo in patients with osteoarthritis.
Clinical therapeutics.
1999 Mar; 21(3):503-12. doi:
10.1016/s0149-2918(00)88305-8. [PMID: 10321419] - C M Magro, A N Crowson. Pseudoporphyria associated with Relafen therapy.
Journal of cutaneous pathology.
1999 Jan; 26(1):42-7. doi:
10.1111/j.1600-0560.1999.tb01789.x. [PMID: 10189244] - R Rothstein. Safety profiles of leading nonsteroidal anti-inflammatory drugs.
The American journal of medicine.
1998 Nov; 105(5A):39S-43S. doi:
10.1016/s0002-9343(98)00280-0. [PMID: 9855175] - J A Martin, K Brownbill. When is an indole not an indole?.
Clinical chemistry.
1998 Jan; 44(1):186. doi:
10.1093/clinchem/44.1.186. [PMID: 9550580] - N M Davies. Clinical pharmacokinetics of nabumetone. The dawn of selective cyclo-oxygenase-2 inhibition?.
Clinical pharmacokinetics.
1997 Dec; 33(6):404-16. doi:
10.2165/00003088-199733060-00001. [PMID: 9435990] - M E Cook, J D Wallin, V D Thakur, P J Kadowitz, D B McNamara, M M Garcia, J A Lipani, M Poland. Comparative effects of nabumetone, sulindac, and ibuprofen on renal function.
The Journal of rheumatology.
1997 Jun; 24(6):1137-44. doi:
NULL. [PMID: 9195523] - R Büschges, R Devant, E Mutschler, H Spahn-Langguth. 4-(6-methoxy-2-naphthyl)-2-butyl chloroformate enantiomers: new reagents for the enantiospecific analysis of amino compounds in biogenic matrices.
Journal of pharmaceutical and biomedical analysis.
1996 Nov; 15(2):201-20. doi:
10.1016/0731-7085(96)01817-1. [PMID: 8933422] - M Ionac, R Oelkers, K Brune, G Geisslinger, D Bordos. Lymph distribution of different non-steroidal anti-inflammatory drugs assessed by microsurgical cannulation of the thoracic duct in rat.
Romanian journal of internal medicine = Revue roumaine de medecine interne.
1996 Jul; 34(3-4):239-51. doi:
NULL. [PMID: 9167225] - L R Soma, C E Uboh, J A Rudy, M S Smith. Disposition and excretion of 6-methoxy-2-naphthylacetic acid, the active metabolite of nabumetone in horses.
American journal of veterinary research.
1996 Apr; 57(4):517-21. doi:
NULL. [PMID: 8712517] - F Cipollone, A Ganci, M R Panara, A Greco, F Cuccurullo, C Patrono, P Patrignani. Effects of nabumetone on prostanoid biosynthesis in humans.
Clinical pharmacology and therapeutics.
1995 Sep; 58(3):335-41. doi:
10.1016/0009-9236(95)90251-1. [PMID: 7554708] - E Blackwell, K Loughlin, F Dumler, M Smythe. Nabumetone-associated interstitial nephritis.
Pharmacotherapy.
1995 Sep; 15(5):669-72. doi:
10.1002/j.1875-9114.1995.tb02878.x. [PMID: 8570441] - T J Schnitzer, I M Ballard, G Constantine, P McDonald. Double-blind, placebo-controlled comparison of the safety and efficacy of orally administered etodolac and nabumetone in patients with active osteoarthritis of the knee.
Clinical therapeutics.
1995 Jul; 17(4):602-12. doi:
10.1016/0149-2918(95)80037-9. [PMID: 8565024] - M E Brier, R S Sloan, G R Aronoff. Population pharmacokinetics of the active metabolite of nabumetone in renal dysfunction.
Clinical pharmacology and therapeutics.
1995 Jun; 57(6):622-7. doi:
10.1016/0009-9236(95)90224-4. [PMID: 7781261] - D Young, C Peterson, C Basch, S C Halladay. Effects of naproxen and nabumetone on serum cholesterol levels in patients with osteoarthritis.
Clinical therapeutics.
1995 Mar; 17(2):231-40. doi:
10.1016/0149-2918(95)80021-2. [PMID: 7614523] - A Barth, N Kaiser, U Löffler, H Sourgens, W Klinger. Influence of the xanthine derivative denbufylline and the anti-inflammatory agent nabumetone on microsomal free radical production and lipid peroxidation in rat liver.
Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.
1994 Dec; 46(6):483-9. doi:
10.1016/s0940-2993(11)80067-9. [PMID: 7703681] - M I Freed, P R Audet, N Zariffa, G G Krishna, B E Ilson, D E Everitt, L E Brown, S M Rizzo, A I Nichols, D K Jorkasky. Comparative effects of nabumetone, sulindac, and indomethacin on urinary prostaglandin excretion and platelet function in volunteers.
Journal of clinical pharmacology.
1994 Nov; 34(11):1098-108. doi:
10.1002/j.1552-4604.1994.tb01987.x. [PMID: 7876402] - R Melarange, C Gentry, P R Blower, C D Toseland, R Spangler. Nabumetone, an effective anti-inflammatory agent, lacks gastrointestinal irritancy in the rat when dosed orally for one month: comparison with tiaprofenic acid and etodolac.
European journal of rheumatology and inflammation.
1994; 14(2):15-22. doi:
. [PMID: 7744129] - D Giannessi, G Lazzerini, P Filipponi, C Mannarelli, G Vaiani, E Grossi, R De Caterina. Effects of nabumetone, a new non-steroidal anti-inflammatory drug, on urinary prostaglandin excretion in man.
Pharmacological research.
1993 Oct; 28(3):229-41. doi:
10.1006/phrs.1993.1126. [PMID: 8108313] - R De Caterina, D Giannessi, G Lazzerini, P Filipponi, C Mannarelli, G Vaiani, E Grossi. Effect of nabumetone on metabolism of renal arachidonate in humans.
The Journal of rheumatology. Supplement.
1992 Nov; 36(?):80. doi:
NULL. [PMID: 1474540] - I Bjarnason, B Fehilly, P Smethurst, I S Menzies, A J Levi. Effects of nonsteroidal antiinflammatory drugs on permeability of the small intestine in humans.
The Journal of rheumatology. Supplement.
1992 Nov; 36(?):83-4. doi:
NULL. [PMID: 1474542] - G R Aronoff. Therapeutic implications associated with renal studies of nabumetone.
The Journal of rheumatology. Supplement.
1992 Nov; 36(?):25-31. doi:
NULL. [PMID: 1474532] - M L Hyneck. An overview of the clinical pharmacokinetics of nabumetone.
The Journal of rheumatology. Supplement.
1992 Nov; 36(?):20-4. doi:
NULL. [PMID: 1474531] - R K Miehlke, S Schneider, F Sörgel, P Muth, F Henschke, M Fedder. [6-methoxy-2-naphthylacetic acid level in plasma, synovial fluid and adjacent tissue in patients with rheumatoid arthritis or gonarthroses after a 4-day therapy with nabumetone (Arthaxan)].
Zeitschrift fur Rheumatologie.
1991 Mar; 50(2):103-8. doi:
NULL. [PMID: 1872041] - I Bjarnason, B Fehilly, P Smethurst, I S Menzies, A J Levi. Importance of local versus systemic effects of non-steroidal anti-inflammatory drugs in increasing small intestinal permeability in man.
Gut.
1991 Mar; 32(3):275-7. doi:
10.1136/gut.32.3.275. [PMID: 1901563] - M Ip, D A Lomas, J Shaw, D Burnett, R A Stockley. Effect of non-steroidal anti-inflammatory drugs on neutrophil chemotaxis--an in vitro and in vivo study.
British journal of rheumatology.
1990 Oct; 29(5):363-7. doi:
10.1093/rheumatology/29.5.363. [PMID: 2224405] - S Sartini, F Zuffa, C Menarini, G Vaiani. [Osteoarthritis and analgesic-antiphlogistic therapy. Preliminary report on the tolerability and efficacy of nabumetone treatment].
La Clinica terapeutica.
1990 Jul; 134(1):31-9. doi:
NULL. [PMID: 2147607] - R F Willkens. An overview of the long-term safety experience of nabumetone.
Drugs.
1990; 40 Suppl 5(?):34-7. doi:
10.2165/00003495-199000405-00008. [PMID: 2081490] - R K Miehlke, S Schneider, F Sörgel, P Muth, F Henschke, K H Giersch, P Münzel. Penetration of the active metabolite of nabumetone into synovial fluid and adherent tissue of patients undergoing knee joint surgery.
Drugs.
1990; 40 Suppl 5(?):57-61. doi:
10.2165/00003495-199000405-00014. [PMID: 2081495] - M J Kendall, M C Chellingsworth, R Jubb, A R Thawley, N A Undre, D C Kill. A pharmacokinetic study of the active metabolite of nabumetone in young healthy subjects and older arthritis patients.
European journal of clinical pharmacology.
1989; 36(3):299-305. doi:
10.1007/bf00558163. [PMID: 2744071] - D Torre, C Sampietro, F Maggiolo. Blood and tissue fluid levels of a new non-steroidal anti-inflammatory preparation of nabumetone.
The Journal of international medical research.
1987 Nov; 15(6):368-73. doi:
10.1177/030006058701500606. [PMID: 3436484] - E A Daigneault, K E Ferslew, P Stanton. Bioequivalence study of nabumetone: tablet versus suspension.
The American journal of medicine.
1987 Oct; 83(4B):11-4. doi:
10.1016/0002-9343(87)90586-9. [PMID: 3687999] - F R Mangan, J D Flack, D Jackson. Preclinical overview of nabumetone. Pharmacology, bioavailability, metabolism, and toxicology.
The American journal of medicine.
1987 Oct; 83(4B):6-10. doi:
10.1016/0002-9343(87)90585-7. [PMID: 3688000] - J R Boelaert, H A Jonnaert, R F Daneels, M L Schurgers, A R Thawley, N A Undre, D L Cooper. Nabumetone pharmacokinetics in patients with varying degrees of renal impairment.
The American journal of medicine.
1987 Oct; 83(4B):107-9. doi:
10.1016/0002-9343(87)90606-1. [PMID: 3687998] - F G McMahon, R Vargas, J R Ryan, D A Fitts. Nabumetone kinetics in the young and elderly.
The American journal of medicine.
1987 Oct; 83(4B):92-5. doi:
10.1016/0002-9343(87)90603-6. [PMID: 3688002] - D Terziivanov, A Maleev, V Vlahov. Nabumetone (BRL 14777) presystemic elimination and disposition in patients with liver impairments.
International journal of clinical pharmacology, therapy, and toxicology.
1987 Apr; 25(4):208-13. doi:
NULL. [PMID: 2884189] - A Maleev, V Vlahov, I Gruev, D Dierdorf, N Kostova, N Bacracheva. Liver insufficiency as a factor modifying the pharmacokinetic characteristic of the preparation nabumetone.
International journal of clinical pharmacology, therapy, and toxicology.
1986 Aug; 24(8):425-9. doi:
NULL. [PMID: 3759278] - J E Ray, R O Day. High-performance liquid chromatographic determination of a new anti-inflammatory agent, nabumetone, and its major metabolite in plasma using fluorimetric detection.
Journal of chromatography.
1984 Dec; 336(1):234-8. doi:
10.1016/s0378-4347(00)85146-4. [PMID: 6526922] - H W von Schrader, G Buscher, D Dierdorf, H Mügge, D Wolf. Nabumetone--a novel anti-inflammatory drug: bioavailability after different dosage regimens.
International journal of clinical pharmacology, therapy, and toxicology.
1984 Dec; 22(12):672-6. doi:
NULL. [PMID: 6526543] - R E Haddock, D J Jeffery, J A Lloyd, A R Thawley. Metabolism of nabumetone (BRL 14777) by various species including man.
Xenobiotica; the fate of foreign compounds in biological systems.
1984 Apr; 14(4):327-37. doi:
10.3109/00498258409151419. [PMID: 6464502] - L A Verbruggen, H Pintens. Efficacy and safety of nabumetone in long-term treatment of osteoarthritis.
International journal of tissue reactions.
1984; 6(4):339-42. doi:
NULL. [PMID: 6396271] - R E Haddock, D J Jeffery, F R Mangan, I S Pardon. Penetration of nabumetone into inflammatory exudates in the rat.
The Journal of pharmacy and pharmacology.
1983 Jun; 35(6):358-62. doi:
10.1111/j.2042-7158.1983.tb02956.x. [PMID: 6135773] - H W von Schrader, G Buscher, D Dierdorf, H Mügge, D Wolf. Nabumetone--a novel anti-inflammatory drug: the influence of food, milk, antacids, and analgesics on bioavailability of single oral doses.
International journal of clinical pharmacology, therapy, and toxicology.
1983 Jun; 21(6):311-21. doi:
NULL. [PMID: 6688407]